Background Exercise rehabilitation is demonstrated to improve the prognosis of patients with coronary heart disease (CHD). Statins, as the key medicine to lower cholesterol in CHD, result in skeletal muscle injury and impair exercise training adaptation.
Ming Song +10 more
doaj +1 more source
Влияние триметазидина на активность митохондрий пациентов со стабильной стенокардией напряжения [PDF]
Определение индивидуальной чувствительности митохондрий пациентов со стабильной стенокардией напряжения к введению ...
Ромащенко, О. В.
core +1 more source
Response to Letter Regarding Article, “Trimetazidine, a Metabolic Modulator, Has Cardiac and Extracardiac Benefits in Idiopathic Dilated Cardiomyopathy” [PDF]
Helena Tuunanen +2 more
openalex +1 more source
Trimetazidine as a Modifier of Chemotherapy-Induced Cardiovascular Redox-Homeostasis Disturbances
А.А. Авагимян +2 more
openalex +1 more source
CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation [PDF]
CD40 is a 48-kDa phosphorylated transmembrane glycoprotein belonging to the TNF receptor superfamily. CD40 has been demonstrated on a range of cell types, and it has an important role in adaptive immunity and inflammation.
Callard, R.E. +4 more
core
Cliniko-experimental research of trimetazidine efficiency at the myocardium ischemia
The randomized controllable clinical research of Trimetazidine (Preductal MB) efficiency was spent at 95 patients with a stable angina pectoris. There were revealed the authentic increase in 2 times of treatment’s clinical efficiency in patients, who in ...
O. V Romashchenko
doaj
THE ACTIONS OF TRIMETAZIDINE ON ISOLATED GUINEA-PIG ATRIA
Mitsuhiro Nagata +3 more
openalex +2 more sources
The Impact of Trimetazidine on Disease Severity and Quality of Life in Parkinson’s Disease [PDF]
Dávid Pintér +4 more
openalex +1 more source
Trimetazidine Reduces Endogenous Free Fatty Acid Oxidation and Improves Myocardial Efficiency in Obese Humans [PDF]
Marco Bucci +16 more
openalex +1 more source
Aim. To assess the effect of a long-term (6 months) treatment with selective beta-blocker bisoprolol, cytoprotector trimetazidine and their combination on the clinical course, left ventricular morphofunctional parameters and quality of life of patients ...
Т A Fedorova +4 more
doaj

